TY  - CONF

T1  - Non-myeloablative hematopoietic stem cell transplantation (HSCT) is superior to disease modifying drug (DMD) treatment in highly active Relapsing Remitting Multiple Sclerosis (RRMS): interim results of the Multiple Sclerosis International Stem cell Transplant (MIST) Randomized Trial

JO  - NEUROLOGY

PY  - 2018/04/10

AU  - Burt RK

AU  - Balabanov R

AU  - Snowden JA

AU  - Sharrack B

AU  - Oliveira MC

AU  - Burman J

ED  - 

VL  - 90

Y2  - 2024/12/26

ER  -